Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primary Health Care | 30 | 2025 | 169 | 5.380 |
Why?
|
| Rural Health Services | 3 | 2025 | 26 | 2.100 |
Why?
|
| Quality Improvement | 7 | 2021 | 127 | 1.880 |
Why?
|
| Family Practice | 6 | 2021 | 47 | 1.690 |
Why?
|
| Patient-Centered Care | 4 | 2025 | 38 | 1.620 |
Why?
|
| Preventive Health Services | 4 | 2020 | 16 | 1.620 |
Why?
|
| Internet | 9 | 2015 | 128 | 1.540 |
Why?
|
| Health Services Research | 7 | 2025 | 45 | 1.290 |
Why?
|
| Self Care | 5 | 2016 | 42 | 1.090 |
Why?
|
| Physician-Patient Relations | 6 | 2021 | 119 | 1.080 |
Why?
|
| Community-Based Participatory Research | 2 | 2025 | 39 | 1.030 |
Why?
|
| Rural Population | 4 | 2025 | 137 | 1.000 |
Why?
|
| Stakeholder Participation | 1 | 2025 | 7 | 0.940 |
Why?
|
| Electronic Health Records | 4 | 2020 | 67 | 0.930 |
Why?
|
| Preventive Medicine | 3 | 2021 | 14 | 0.920 |
Why?
|
| Oklahoma | 13 | 2020 | 1058 | 0.850 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2025 | 125 | 0.830 |
Why?
|
| Medical Informatics | 2 | 2014 | 13 | 0.830 |
Why?
|
| Humans | 49 | 2026 | 28998 | 0.820 |
Why?
|
| Communication | 2 | 2022 | 184 | 0.770 |
Why?
|
| Health Information Exchange | 3 | 2020 | 6 | 0.720 |
Why?
|
| Models, Organizational | 2 | 2020 | 18 | 0.690 |
Why?
|
| Delivery of Health Care | 4 | 2018 | 119 | 0.650 |
Why?
|
| Quality of Life | 3 | 2026 | 523 | 0.620 |
Why?
|
| Pilot Projects | 8 | 2021 | 464 | 0.620 |
Why?
|
| Patient Education as Topic | 3 | 2012 | 92 | 0.610 |
Why?
|
| Goals | 3 | 2018 | 34 | 0.600 |
Why?
|
| Cancer Survivors | 3 | 2026 | 72 | 0.600 |
Why?
|
| Advance Directives | 1 | 2019 | 13 | 0.590 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2022 | 104 | 0.590 |
Why?
|
| Neoplasms | 3 | 2025 | 879 | 0.590 |
Why?
|
| Physicians, Family | 2 | 2017 | 14 | 0.580 |
Why?
|
| Community-Institutional Relations | 2 | 2018 | 15 | 0.570 |
Why?
|
| Health Care Reform | 1 | 2018 | 13 | 0.550 |
Why?
|
| Documentation | 1 | 2018 | 28 | 0.550 |
Why?
|
| Computer-Assisted Instruction | 2 | 2012 | 33 | 0.550 |
Why?
|
| Cooperative Behavior | 3 | 2025 | 78 | 0.520 |
Why?
|
| Middle Aged | 17 | 2026 | 7428 | 0.490 |
Why?
|
| Prothrombin Time | 1 | 2016 | 21 | 0.480 |
Why?
|
| International Normalized Ratio | 1 | 2016 | 27 | 0.480 |
Why?
|
| Drug Monitoring | 1 | 2016 | 36 | 0.480 |
Why?
|
| Warfarin | 1 | 2016 | 94 | 0.460 |
Why?
|
| Inventions | 1 | 2014 | 5 | 0.450 |
Why?
|
| Feasibility Studies | 6 | 2025 | 225 | 0.450 |
Why?
|
| Male | 21 | 2026 | 13983 | 0.440 |
Why?
|
| Aged | 14 | 2026 | 5608 | 0.430 |
Why?
|
| Public Health | 2 | 2024 | 97 | 0.420 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2014 | 10 | 0.420 |
Why?
|
| Female | 21 | 2025 | 15690 | 0.410 |
Why?
|
| Anticoagulants | 1 | 2016 | 297 | 0.410 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 221 | 0.390 |
Why?
|
| Health | 1 | 2013 | 12 | 0.390 |
Why?
|
| Health Status Indicators | 1 | 2013 | 25 | 0.390 |
Why?
|
| Adult | 16 | 2026 | 8048 | 0.380 |
Why?
|
| Physicians | 3 | 2023 | 83 | 0.370 |
Why?
|
| Qualitative Research | 3 | 2025 | 206 | 0.350 |
Why?
|
| United States | 9 | 2022 | 2247 | 0.330 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2022 | 177 | 0.320 |
Why?
|
| Calcium Channels, L-Type | 2 | 2000 | 9 | 0.320 |
Why?
|
| Health Promotion | 2 | 2018 | 179 | 0.320 |
Why?
|
| Information Systems | 1 | 2010 | 7 | 0.320 |
Why?
|
| Telephone | 1 | 2010 | 26 | 0.310 |
Why?
|
| Quality Assurance, Health Care | 2 | 2008 | 64 | 0.310 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2015 | 68 | 0.300 |
Why?
|
| Influenza, Human | 2 | 2010 | 95 | 0.300 |
Why?
|
| Survivorship | 2 | 2025 | 16 | 0.280 |
Why?
|
| Telecommunications | 1 | 2008 | 4 | 0.280 |
Why?
|
| Systems Integration | 1 | 2007 | 3 | 0.260 |
Why?
|
| Sweating | 1 | 2006 | 4 | 0.250 |
Why?
|
| Private Sector | 1 | 2006 | 3 | 0.250 |
Why?
|
| Risk Assessment | 2 | 2020 | 631 | 0.250 |
Why?
|
| Population Surveillance | 1 | 2006 | 87 | 0.240 |
Why?
|
| Sleep Wake Disorders | 1 | 2006 | 65 | 0.240 |
Why?
|
| Capacity Building | 1 | 2025 | 9 | 0.240 |
Why?
|
| Practice Management | 1 | 2005 | 4 | 0.240 |
Why?
|
| Counseling | 1 | 2025 | 61 | 0.230 |
Why?
|
| Health Personnel | 1 | 2006 | 99 | 0.230 |
Why?
|
| Continuity of Patient Care | 1 | 2025 | 33 | 0.230 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 56 | 0.230 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 381 | 0.220 |
Why?
|
| Mental Health | 2 | 2015 | 111 | 0.210 |
Why?
|
| Multiple Chronic Conditions | 1 | 2023 | 4 | 0.210 |
Why?
|
| Resilience, Psychological | 1 | 2023 | 18 | 0.190 |
Why?
|
| Prostatic Neoplasms | 1 | 2026 | 302 | 0.190 |
Why?
|
| Burnout, Professional | 1 | 2023 | 21 | 0.190 |
Why?
|
| Aged, 80 and over | 4 | 2026 | 2067 | 0.190 |
Why?
|
| Glaucoma | 1 | 2022 | 53 | 0.180 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 154 | 0.180 |
Why?
|
| Mental Health Services | 1 | 2022 | 20 | 0.180 |
Why?
|
| Smoking Cessation | 2 | 2025 | 427 | 0.180 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 51 | 0.170 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 1004 | 0.170 |
Why?
|
| Indians, North American | 1 | 2025 | 544 | 0.170 |
Why?
|
| Research Personnel | 1 | 2021 | 40 | 0.170 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 137 | 0.160 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2000 | 23 | 0.160 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2000 | 22 | 0.160 |
Why?
|
| Blood Pressure Determination | 1 | 2020 | 28 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2026 | 413 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 142 | 0.160 |
Why?
|
| Decision Making | 1 | 2021 | 179 | 0.160 |
Why?
|
| Heart Ventricles | 1 | 2000 | 139 | 0.160 |
Why?
|
| Ventricular Function | 1 | 1999 | 25 | 0.150 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1999 | 24 | 0.150 |
Why?
|
| Chronic Disease | 2 | 2022 | 274 | 0.150 |
Why?
|
| Aspirin | 1 | 2020 | 125 | 0.150 |
Why?
|
| Myocardium | 1 | 2000 | 197 | 0.150 |
Why?
|
| Health Literacy | 1 | 2019 | 34 | 0.140 |
Why?
|
| Smoking | 2 | 2020 | 478 | 0.140 |
Why?
|
| Calcium | 1 | 1999 | 243 | 0.140 |
Why?
|
| Mass Screening | 2 | 2022 | 159 | 0.140 |
Why?
|
| Adolescent | 3 | 2017 | 3223 | 0.130 |
Why?
|
| Community Health Planning | 1 | 2017 | 14 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 116 | 0.130 |
Why?
|
| Program Development | 2 | 2015 | 88 | 0.130 |
Why?
|
| Telemedicine | 2 | 2026 | 214 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2017 | 134 | 0.130 |
Why?
|
| Medicare | 1 | 2017 | 126 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 1 | 2016 | 33 | 0.120 |
Why?
|
| Pets | 1 | 2015 | 2 | 0.120 |
Why?
|
| Child Health | 1 | 2015 | 18 | 0.120 |
Why?
|
| Young Adult | 3 | 2018 | 2842 | 0.120 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2015 | 5 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 65 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 46 | 0.110 |
Why?
|
| Office Visits | 1 | 2015 | 11 | 0.110 |
Why?
|
| Evidence-Based Medicine | 2 | 2021 | 148 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 2 | 2020 | 54 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 1011 | 0.100 |
Why?
|
| Dogs | 3 | 2015 | 510 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2022 | 249 | 0.100 |
Why?
|
| Motivation | 1 | 2014 | 217 | 0.100 |
Why?
|
| Program Evaluation | 2 | 2018 | 176 | 0.090 |
Why?
|
| Lung | 1 | 2015 | 385 | 0.090 |
Why?
|
| Software Design | 1 | 2012 | 7 | 0.090 |
Why?
|
| Attitude to Computers | 1 | 2012 | 7 | 0.090 |
Why?
|
| Data Collection | 3 | 2022 | 109 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2012 | 77 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 430 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 303 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 96 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2012 | 1196 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2025 | 162 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 2 | 2000 | 31 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2015 | 415 | 0.080 |
Why?
|
| Electronic Mail | 1 | 2009 | 10 | 0.080 |
Why?
|
| Child | 2 | 2015 | 2327 | 0.080 |
Why?
|
| Patient Preference | 1 | 2009 | 34 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 788 | 0.070 |
Why?
|
| Community Networks | 1 | 2008 | 11 | 0.070 |
Why?
|
| Registries | 1 | 2010 | 398 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2008 | 12 | 0.070 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 21 | 0.060 |
Why?
|
| Hot Flashes | 1 | 2006 | 6 | 0.060 |
Why?
|
| Patient Care | 1 | 2005 | 14 | 0.060 |
Why?
|
| Self Efficacy | 1 | 2025 | 80 | 0.060 |
Why?
|
| Mobile Applications | 1 | 2026 | 81 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2006 | 271 | 0.060 |
Why?
|
| Smokers | 1 | 2025 | 129 | 0.050 |
Why?
|
| Life Expectancy | 1 | 2021 | 23 | 0.040 |
Why?
|
| Urban Population | 2 | 2015 | 95 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2021 | 51 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2021 | 97 | 0.040 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2000 | 4 | 0.040 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2000 | 6 | 0.040 |
Why?
|
| Adrenergic Agonists | 1 | 2000 | 6 | 0.040 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2000 | 4 | 0.040 |
Why?
|
| Colforsin | 1 | 2000 | 12 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2000 | 12 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 2000 | 6 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2000 | 32 | 0.040 |
Why?
|
| Epinephrine | 1 | 2000 | 37 | 0.040 |
Why?
|
| Animals | 3 | 2015 | 10715 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2000 | 66 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 57 | 0.040 |
Why?
|
| Ion Transport | 1 | 1999 | 11 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 612 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 191 | 0.040 |
Why?
|
| Multimorbidity | 1 | 2017 | 3 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2018 | 84 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2000 | 1022 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 63 | 0.030 |
Why?
|
| Quality Control | 1 | 2015 | 21 | 0.030 |
Why?
|
| Peer Group | 1 | 2015 | 38 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 6 | 0.030 |
Why?
|
| Community Health Services | 1 | 2015 | 34 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 100 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 310 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 16 | 0.030 |
Why?
|
| Learning | 1 | 2015 | 100 | 0.030 |
Why?
|
| Video Recording | 1 | 2015 | 41 | 0.030 |
Why?
|
| Body Weight | 1 | 2015 | 253 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 415 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 200 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2015 | 90 | 0.030 |
Why?
|
| Motor Activity | 1 | 2015 | 148 | 0.030 |
Why?
|
| Research Design | 1 | 2015 | 188 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 470 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 740 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1619 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 2427 | 0.020 |
Why?
|
| Benchmarking | 1 | 2008 | 33 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 121 | 0.020 |
Why?
|